SAVCIO Holdings (Proprietary) Ltd.

  • ID: 1771545
  • Standard & Poors
1 of 3

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research Type: Full Analysis

South Africa's leading provider of repair and maintenance services for large electric motors and transformers. Long record of customer service. Stable profitability translating into solid free cash flow generation. Broad customer base in diverse end markets. Aggressive financial profile. Currency risk from euro-denominated debt financing. Small size and lack of geographic and product diversity. Working-capital intensity. Shareholder-friendly financial policy. Uncertainty regarding future ownership structure. The rating on South Africa-based heavy capital goods repair and maintenance company SAVCIO Holdings (Proprietary) Ltd. reflects what we consider a weak business risk profile and an aggressive financial risk profile. The rating is constrained by SAVCIO's relatively small size and its lack of geographic and product diversity because the vast majority of profits are generated...

Companies mentioned in this report are: SAVCIO Holdings (Proprietary) Ltd.
Action: Review

Note: Product cover images may vary from those shown
2 of 3

SAVCIO Holdings (Proprietary) Ltd.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.